CU Cancer Center test identifies key biomarkers in advanced lung cancer Identifies key proteins, boon for personalized medicineResearchers at the University of Colorado Cancers Center have developed a check that identifies key biomarkers in advanced lung tumor that helped decrease the threat of death by 36 % over a 30 – month period in a recent clinical trial. ‘We are moving from a one-size-fits-all model to more personalized medication in lung malignancy,’ said University of Colorado College of Medicine Professor Fred R. Hirsch, MD, Ph lady-era.net .D., a Cancer Middle investigator who developed the check along with colleague Wilbur Franklin, MD.
CTS awarded new advancement and production system for piezoelectric micro actuators CTS Company today announced that CTS Electronic Components was awarded a major new development and production program for piezoelectric micro actuators for data storage space devices . Production is expected to begin in the fourth quarter 2010 with total revenues over the next three years to be approximately $14 million and over $10 – $12 million annually thereafter. The awarded program is portion of the grouped family of piezoceramic formulations CTS has developed in response to growing market opportunities. The micro actuator includes patented technology.